首页|不同剂量甲泼尼龙联合阿奇霉素治疗成人难治性支原体肺炎的效果比较

不同剂量甲泼尼龙联合阿奇霉素治疗成人难治性支原体肺炎的效果比较

扫码查看
目的:观察不同剂量甲泼尼龙联合阿奇霉素对成人难治性支原体肺炎(RMPP)的疗效.方法:选取 2021 年 9月—2023 年 8 月在秭归县中医医院治疗的 198 例RMPP患者,按随机数字表法分成A组(n=66)、B组(n=66)和C组(n=66).三组均应用阿奇霉素,在此基础上A组应用低剂量[1mg/(kg·d)]甲泼尼龙治疗,B组应用中剂量[2mg/(kg·d)]甲泼尼龙治疗,C组应用高剂量[5mg/(kg·d)]甲泼尼龙治疗.比较三组疗效、症状改善时间、血清炎症指标[白细胞介素-6(IL-6)、血沉(ESR)、干扰素-γ(IFN-γ)及白细胞计数(WBC)]、血气分析指标[动脉血氧分压(PaO2)、二氧化碳分压(PaCO2)]水平及药物不良反应(ADR).结果:C组总有效率为93.94%,高于A组、B组的78.79%、81.82%(P<0.05);C组止咳、体温复常、肺啰音消失时间短于A组、B组(P<0.05);C组治疗 10 d后血清IL-6、ESR、IFN-γ、WBC水平及PaCO2 均低于A组、B组,PaO2 高于A组、B组(P<0.05);A组、B组、C组ADR总发生率比较,差异无统计学意义(P>0.05).结论:高剂量甲泼尼龙联合阿奇霉素对RMPP患者的治疗效果更佳,可有效改善炎症状况、血气分析指标,明显缩短各症状消失时间,且ADR较低.
Comparison of the Effects of Different Doses of Methylprednisolone Combined with Azithromycin in the Treatment of Adult with Refractory Mycoplasma Pneumonia
Objective:To observe the effect of different doses of methylprednisolone combined with azithromycin in aldult with refractory mycoplasma pneumoniae pneumonia(RMPP).Methods:From September 2021 to August 2023,198 aldult with RMPP who were treated in Zigui County Traditional Chinese Medicine Hospital were randomly separated into group A(n=66),group B(n=66),and group C(n=66)using a random number table method.All three groups were treated with azithromycin,on this basis,group A received low-dose[1 mg/(kg·d)]methylprednisolone treatment,group B received medium dose[2 mg/(kg·d)]methylprednisolone treatment,and group C received high-dose[5 mg/(kg·d)]methylprednisolone treatment.The efficacy,the symptom improvement time,the levels of serum inflammatory indicators[interleukin-6(IL-6),erythrocyte sedimentation rate(ESR),interferon-γ(IFN-γ)and white blood cell(WBC)],blood gas analysis indicators[arterial oxygen partial pressure(PaO2),carbon dioxide partial pressure(PaCO2)]and adverse drug reactions(ADRs)were compared among three groups.Results:The total effective rate of group C was 93.94%,which was higher than 78.79%and 81.82%of group A and group B(P<0.05).The disappearance time of cough,body temperature normalization and pulmonary rales in group C was shorter than that in group A and group B(P<0.05).After 10 days of treatment,the levels of serum IL-6,ESR,IFN-γ,WBC and PaCO2 in group C were lower than those in group A and group B,and PaO2 was higher than that in group A and group B(P<0.05).There was no significant difference in the total incidence of ADR among group A,group B and group C(P>0.05).Conclusion:The combination of high-dose methylprednisolone and azithromycin has a better therapeutic effect on aldult with RMPP,which can effectively improve inflammation status,blood gas analysis indicators,obviously shorten the time of symptom disappearance,and have a lower ADR.

MethylprednisoloneAzithromycinRefractory mycoplasma Pneumoniae pneumoniaBlood gas analysis

韩海峰

展开 >

秭归县中医医院重症医学科,湖北 秭归 443600

甲泼尼龙 阿奇霉素 难治性支原体肺炎 血气分析

湖北省自然科学基金项目

2022CFD144

2024

中国药物滥用防治杂志
中国药物滥用防治协会 军事医学科学院毒物药物研究所

中国药物滥用防治杂志

影响因子:0.584
ISSN:1006-902X
年,卷(期):2024.30(9)
  • 9